Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 2
62
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice

, , , , , & show all
Pages 197-210 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stephanie Kate Sandiford. (2020) An overview of lantibiotic biosynthetic machinery promiscuity and its impact on antimicrobial discovery. Expert Opinion on Drug Discovery 15:3, pages 373-382.
Read now
Stephanie Kate Sandiford. (2019) Current developments in lantibiotic discovery for treating Clostridium difficile infection. Expert Opinion on Drug Discovery 14:1, pages 71-79.
Read now
Auke Johan van Heel, Manuel Montalban-Lopez & Oscar P Kuipers. (2011) Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 675-680.
Read now

Articles from other publishers (12)

Ernst Eber, Maria Trawinska-Bartnicka, Dorota Sands, Gabriel Bellon, Uwe Mellies, Katalin Bolbás, Serena Quattrucci, Henryk Mazurek, Rudolf Widmann, Christian Schoergenhofer, Bernd Jilma & Felix Ratjen. (2021) Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis – a randomized trial. Journal of Cystic Fibrosis 20:1, pages 61-67.
Crossref
Daniel S. Nielsen, Nicholas E. Shepherd, Weijun Xu, Andrew J. Lucke, Martin J. Stoermer & David P. Fairlie. (2017) Orally Absorbed Cyclic Peptides. Chemical Reviews 117:12, pages 8094-8128.
Crossref
Lindsay M. Repka, Jonathan R. Chekan, Satish K. Nair & Wilfred A. van der Donk. (2017) Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes. Chemical Reviews 117:8, pages 5457-5520.
Crossref
Elvis Legala Ongey, Hüseyin Yassi, Stephan Pflugmacher & Peter Neubauer. (2017) Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies. Biotechnology Letters 39:4, pages 473-482.
Crossref
Neha Garg, Yuki Goto, Ting Chen & Wilfred A. van der Donk. (2016) Characterization of the stereochemical configuration of lanthionines formed by the lanthipeptide synthetase GeoM. Biopolymers 106:6, pages 834-842.
Crossref
IGOR OLIYNYK, GEORGIA VARELOGIANNI, GODFRIED M. ROOMANS & MARIE JOHANNESSON. (2010) Effect of duramycin on chloride transport and intracellular calcium concentration in cystic fibrosis and non‐cystic fibrosis epithelia. APMIS 118:12, pages 982-990.
Crossref
Ilka Steiner, Peter Errhalt, Klaus Kubesch, Marianne Hubner, Marion Holy, Martin Bauer, Markus Müller, Sabine Hinterberger, Rudolf Widmann, Daniel Mascher, Michael Freissmuth & Meinhard Kneussl. (2008) Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers. Naunyn-Schmiedeberg's Archives of Pharmacology 378:3, pages 323-333.
Crossref
Scott H. Donaldson. (2008) Hydrator therapies for cystic fibrosis lung disease. Pediatric Pulmonology 43:S9, pages S18-S23.
Crossref
Eva Zebedin, Xaver Koenig, Miroslav Radenkovic, Halyna Pankevych, Hannes Todt, Michael Freissmuth & Karlheinz Hilber. (2008) Effects of duramycin on cardiac voltage-gated ion channels. Naunyn-Schmiedeberg's Archives of Pharmacology 377:1, pages 87-100.
Crossref
Hartmut Grasemann, Florian Stehling, Helmut Brunar, Rudolf Widmann, Terry W. Laliberte, Luis Molina, Gerd Döring & Felix Ratjen. (2007) Inhalation of Moli1901 in Patients With Cystic Fibrosis. Chest 131:5, pages 1461-1466.
Crossref
D.E. Rickert, K. Dingley, E. Ubick, K.J. Dix & L. Molina. (2005) Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation. Chemico-Biological Interactions 155:1-2, pages 55-61.
Crossref
Pamela L. Zeitlin, Michael P. Boyle, William B. Guggino & Luis Molina. (2004) A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis. Chest 125:1, pages 143-149.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.